Mold-Tek Packaging Limited has informed the Exchange about Transcript
MOLDTKPAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mold-Tek Packaging reported strong Q1 FY26 results, with revenue up 22% YoY, EBITDA margin expanding to 19.7% (from ~18%), EBITDA per kg rising 29%, and net profit growing ~35%. The Paint segment led growth, driven mainly by Aditya Birla Group (ABG), while Food & FMCG posted 16% growth despite a weak summer. The Pharma business is the standout story, targeting INR35-36 crore in FY26 (up from INR9-10 crore last year) with multiple new customer approvals (Laurus Labs, Pulse, Gravity, Ajanta) converting to commercial orders. The company guided for full-year volume of 43,000-45,000 tons and revenue growth of 18-20%. Capex of INR80-90 crore is planned for FY26, with total capacity set to rise to 70,000-72,000 tons and a brownfield pharma expansion (INR110-112 crore) targeting peak revenue potential of INR100+ crore. Lubricants remained weak due to early monsoons, while Asian Paints business stabilised after prior year declines.
Broad-based growth and margin expansion across core segments reinforce a positive earnings trajectory. Pharma scaling up materially and improved IML mix (now 77% of value) are structurally margin-accretive, supporting further re-rating potential.